Status:
UNKNOWN
The Healthy Cantonese Diet on Cardiometabolic Syndrome
Lead Sponsor:
Sun Yat-sen University
Conditions:
Cardiovascular Diseases
Cardiovascular Risk Factor
Eligibility:
All Genders
25-75 years
Phase:
NA
Brief Summary
The DASH diet (Dietary Approaches to Stop Hypertension) have been proven to lower risk of cardiovascular diseases. But the DASH diet is inconsistent with Chinese dietary pattern. In this study, based ...
Eligibility Criteria
Inclusion
- Age 25-75 years old, male or female;
- have lived in this community for the past six months, and have no plans to move out or go out in the next three months;
- the systolic blood pressure is within 130-159mmHg regardless of medication.
- maintaining the current medication (mainly drugs for hypertension, diabetes or hyperlipidemia) throughout the research period, with the category and dose unchanged;
- the number of test meal consumed is no less than 18;
- community feeding mode: eat a meal at least once a day at the research center (preferably lunch or dinner); or home delivery mode: upload meal pictures for three meals every day, and eat a meal and have physical examination at the research center at least once a week;
- sign the informed consent form.
Exclusion
- fasting blood glucose ≥10.0mmol/L;
- total cholesterol ≥7.2mmol/L;
- injected inulin within a month;
- unwilling or unable to change the original dietary pattern, or have special dietary needs (such as vegetarians);
- alcoholism;
- BMI ≥30kg/m\^2, or losing weight currently;
- have acute cardiovascular and cerebrovascular events occurred in the past six months;
- have a history of chronic kidney disease, intestinal irritation or asthma;
- women who have been/are preparing for pregnancy or lactation;
- in combination with other serious diseases such as cancer, chronic heart failure, severe depression or other mental disorders, long-term bedridden or unable to move freely;
- have a history of common food allergies (eggs, seafood, peanuts, etc.);
- have undergone gastrointestinal surgery;
- currently suffering from acute phase of diseases such as respiratory infections, fever, severe diarrhea;
- have deaf-mutism, dementia, unable to communicate properly.
Key Trial Info
Start Date :
September 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04064281
Start Date
September 1 2019
End Date
December 31 2022
Last Update
August 21 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.